Should segmentectomy indications be extended to NSCLC smaller than 3 cm without lymph node involvement? A retrospective single-center study
For patients with clinical stage cIA NSCLC, segmentectomy appears to offer comparable oncologic outcomes to lobectomy. Tumor characteristics, including radiological appearance and histological factors, should be carefully considered when selecting the appropriate surgical strategy. Prospective multicenter studies are needed to confirm these findings.
Authors
- Harry Etienne (ORCID: https://orcid.org/0000-0002-9769-279X)
- Aurélie Rousseau (ORCID: https://orcid.org/0000-0001-9296-2933)
- M Roux (ORCID: https://orcid.org/0000-0002-1013-3160)
- Juliette Camuset
- Thérésa Khalife-Hocquemiller
- Mihaëla Giol
- Jalal Assouad (ORCID: https://orcid.org/0000-0003-1409-3351)
- Anna Vayssette (ORCID: https://orcid.org/0009-0009-1701-455X)
- Tristan Goudou
- Soufiane Lebal
- Denis Debrosse
- Damien Leveque
Institutions
- Sorbonne Université (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Hôpital Saint-Antoine (FR)
- Hôpital Tenon (FR)
Publication Details
- Journal
- Respiratory Medicine and Research
- Published
- 2025-05-29
- DOI
- https://doi.org/10.1016/j.resmer.2025.101179
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00